[1]　Bulhak A,Sjoquist PO,Pernow J.Rosuvastatin protects the myocardium against ischemia?reperfusion injury via inhibition of GGPP synthesis[J].Cardiovasc J S Afr,2004,15(4 Suppl 1):S11.

[2]　Jones SP,Gibson MF,Rimmer DM 3rd,et al.Direct vascular and cardioprotective effects of rosuvastatin,a new HMG?CoA reductase inhibitor[J].Jam Coll Cardiol,2002,40(6):1172.

[3]　Di Napoli P,Taccadi AA,Grilli A,et al.Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia?reperfusion injury in rat hearts[J].Cardiovasc Res,2005,66(3):462.

[4]　Bulhak AA,Gourine AV,Gonon AT,et al.Oral pre?treatment with rosuvastatin protects porcine myocardium from ischemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level[J].Acta Physiol Scand,2005,183(2):151.

[5]　Wolfrum S,Dendorfer A,Schutt M,et al.Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3?Kinase/Akt pathway[J].J Cardiovasc Pharmacol,2004,44(3):348.

[6]　Di Napoli P,Maggi A,Spina R,et al.Simvastatin and ischemia?reperfusion damage:its effects on apoptotic myocyte death and on the endothelial expression of nitric?oxide synthetase in an experimental model of the isolated rat heart[J].Cardiologia,1999,44(1):69.

[7]　Scalia R.Statins and the response to myocardial injury[J].Cardiovascular Drugs,2005,5(3):163.

[8]　Lefer AM,Campbell B,Shin YK,et al.Simvastatin preserves the ischemic?reperfused myocardium in normocholesterolemic rat hearts[J].Circulation,1999,100(2):178.

[9]　Metzler B,Mair J,Lercher A,et al.Mouse model of myocardial remodelling after ischemia:role of intercellular adhesion molecule?1[J].Cardiovasc Res,2001,49(2):399.

[10]　Hartman JC,Anderson DC,Wiltse AL,et al.Protection of ischemic/reperfused canine myocardium by CL18/6,a monoclonal antibody to adhesion molecule ICAM?1[J].Cardiovasc Res,1995,30(1):47.

[11]　陈莉，杨波，李建军，等.氟伐他汀对缺血再灌注损伤兔心肌细胞间黏附分子的影响[J].微循环学杂志，2005，15(2):18.

[12]　秦晋梅，杨波，李建军，等.氟伐他汀对高脂血症兔缺血再灌注损伤心肌局部细胞间粘附分子?1的影响[J].中国临床药理学与治疗学，2004，9(11)：1281.

[13]　Scalia R,Gooszen ME,Jones SP,et al.Simvastatin exerts both anti?inflammatory and cardioprotective effects in apolipoprotein E?deficient mice[J].Circulation,2001,103(21):2598.

[14]　Tiefenbacher CP,Kapitza J,Dietaz V,et al.Reduction of myocardial infarct size by fluvastatin[J].Am J Physiol Heart Circ Physiol,2003,285(1):59.

[15]　杨彦玲，刘运德.抗心肌缺血再灌注损伤药物的研究进展[J].心血管病学进展，2003，24(2)：121.

[16]　吴金义，王玲燕，周方均，等.前列腺素E1对心肌缺血再灌注损伤的保护作用[J].中国危重急救医学，1998，10(7)：394.

[17]　Birnbaum Y,Ye Y,Rosanio S,et al.Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia?reperfusion injury[J].Cardiovasc Res,2005,65(2):296.

[18]　Chen J,Nagasawa Y,Zhu BM,et al.Pravastatin prevents arrhythmias induced by coronary artery ischemia/reperfusion in anesthetized normocholesterolemic rats[J].J Pharmacol Sci,2003,93(1):87.

[19]　Light PE.Cardiac K+?ATP channel and ischemic preconditioning:current perspectives[J].Can J Cardiol,1999,15:1123?1130.

[20]　王建春，王曙霞.一氧化氮与心肌缺血预适应[J].心血管病学进展，2003，24(4)：291.

[21]　Tavackoli S,Ashitkov T,Hu ZY,et al.Simvastatin?induced myocardial protection against ischemia?reperfusion injury is

精品学习网 医药卫生栏目